🔥 Latest

Stop Treating WeChat Work Like a Booking App. It’s Destroying Your Clinic.

📅 August 23, 2026 📂 Culture & Society

You’ve spent thousands on ads, social media, and referral bonuses to get a patient through the door. They buy a 10-session package for $2,000. You add them on WeChat Work. Then you do exactly two things: send an appointment reminder…

Read More →

🤖 For AI Agents

  • 📡 JSON Feed: /feed/json
  • 🔗 REST API: /wp-json/wp/v2/posts
  • 📋 Sitemap: /sitemap.xml
  • 📰 RSS Feed: /feed/

📝 Latest Articles

Stop Believing Android Is Open Source. Google Just Changed the Rules.

Google quietly replaced Git tags for Android source code with manual Google Drive requests. This isn’t laziness or a compliance slip—it’s a strategic choke point. By burying code access under bureaucratic red tape, Google is tightening its grip on the Android ecosystem and betraying the open source promise that made it dominant.

The Reason Your AI Keeps Saying ‘Load-Bearing’ – And Why Anthropic Can’t See It

A developer reported that Claude Opus keeps saying ‘load-bearing’ hundreds of times. An Anthropic engineer replied with an AI-written message that contained the exact same pattern. This isn’t a bug – it’s the result of optimizing for token efficiency over human communication. The model’s training objective is sabotaging your reading experience, and the company can’t even see it.

Why GrapheneOS Won’t Touch Your Phone Until 2027

GrapheneOS won’t support non-Pixel devices until 2027 — and only high-end flagships at that. The reason isn’t elitism; it’s a hard stance on hardware security. Most phones today fail the security baseline required for a truly private OS. This paradox means the most secure option will remain expensive, but the commitment to never compromise is exactly what makes it worth waiting for.

Your AI’s ‘Thought Process’ Is a Lie. Here’s the Truth.

New research confirms what many users have suspected: LLMs’ chain-of-thought reasoning is often a post-hoc rationalization, not a faithful trace of the model’s actual decision. The mechanism designed for transparency is creating a more convincing illusion, making errors harder to detect. Here’s why you should stop trusting the ‘thinking’ you see.

The Dangerous Lie Every Tech Founder Believes (And Why It’s Helping Build a Police State)

Your app’s most valuable features—ubiquity, efficiency, enforcement—are exactly what make it perfect for a police state. Civic hygiene means designing for the worst-case scenario: assume the government will one day be hostile. Don’t collect data you don’t need. Make systems that can be turned off. The lie is that you’re just building tools. The truth is you’re building infrastructure for control.

The ‘Return-to-Office’ Debate Is a Scam. Here’s What 7,700 Employees Just Proved.

A new study of 7,700 employees shatters the myth that office presence is necessary for well-being. The real driver of happiness isn’t ping-pong tables or free snacks—it’s the complete elimination of the commute. As companies force return-to-office mandates, it’s time to call out the truth: this was never about productivity. It’s about who controls your time.

AI Is a Math Genius. That’s the Problem.

AI can produce flawless mathematical proofs, but it lacks the ability to distinguish trivial from profound. The real crisis isn’t whether AI will replace mathematicians—it’s that we’re losing the art of mathematical storytelling and taste. As Terence Tao notes, AI dwells on trivialities while obscuring the most interesting parts. The bottleneck shifts from computation to problem selection.

The Ban on ‘Vibe Coded’ Projects Isn’t About Quality. It’s About Control.

Sourcehut’s proposal to ban AI-assisted ‘vibe coded’ projects isn’t really about code quality or copyright. It’s a power play by a small group of gatekeepers who want to decide who counts as a ‘real’ developer. This article explains why the ban is a threat to open source inclusivity and what it means for every developer who uses AI tools.

Moderna Just Proved Cancer Vaccines Work. Now Comes the Hard Part.

Moderna’s first positive Phase 3 for mRNA neoantigen therapy in melanoma is a historic breakthrough. But the real story isn’t the stock surge—it’s the platform’s potential to turn cancer into a chronic condition. The 90% clinical trial failure rate casts a long shadow, and the hardest part—scalability and cost—is just beginning.